Gp Sarl Df II and 5 Others Buys $5M of Cyteir Therapeutics Inc (CYT) — SEC Form 4, Jun 24, 2021

Open-Market Net Purchase · SEC Form 4
+$4,999,986
Reporting Owners
Gp Sarl Df II
10%+
Luc Verelst
10%+
Janwillem Naesens
10%+

+ 3 more

TXN 2021-06-22 · FILED 2021-06-24
Equity Position 3.54M sh 0 → 3,536,803
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Cyteir Therapeutics Inc

CYT CIK 0001662244
All Cyteir Therapeutics Inc insider activity
Filing Date
2021-06-24
Report Date
2021-06-22
Accession No.
0000899243-21-025828
Accepted At
2021-06-24 20:55 UTC
Reporting Owners
Name Relationship
Gp Sarl Df II CIK 0001867855
10% Owner
Luc Verelst CIK 0001867886
10% Owner
Janwillem Naesens CIK 0001864377
10% Owner
Wepaven BV CIK 0001867904
10% Owner
Ihl SA CIK 0001868013
10% Owner
Invest Scsp Droia II CIK 0001867968
10% Owner
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2021-06-22 C - Conversion 3,259,026 A — 3,259,026 Direct
Common StockF2 2021-06-22 P - Purchase 277,777 A $18.00 +$4,999,986 3,536,803 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Series B Convertible Preferred StockF1F1F1F1F2 2021-06-22 C - Conversion 10,000,000 D 2,933,583 Common Stock Direct
Series C Convertible Preferred StockF1F1F1F1F2 2021-06-22 C - Conversion 1,109,368 D 325,443 Common Stock Direct
Footnotes (2)
F1
Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 3.4088:1 upon completion of the Issuer's initial public offering. The shares have no expiration date. Show more
F2
Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Show more

Related filings at Cyteir Therapeutics Inc

Institutional Holders
13F holders · Mar 31, 2024 4 institutional managers reporting a position
Largest by reported value
  1. Bml Capital Management, Llc $11M
  2. Acadian Asset Management Llc $77K
  3. Boston Family Office Llc $73K
Other insiders at Cyteir Therapeutics Inc
All Cyteir Therapeutics Inc insider activity
GET /v1/forms/4/0000899243-21-025828 API docs
View Original SEC Filing